Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitization
J Andrew Bird, Matthew Feldman, Amy Arneson, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 12, 2026
Teff allergy in children with regular household exposure
Vivian Y Liu, Iris-Mae Morse, Aaron I Jaynes, et al.
Gastrointestinal Endoscopy
|
November 27, 2015
The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis
Swathi Eluri, Thomas M Runge, Cary C Cotton, et al.
Biorxiv : the Preprint Server for Biology
|
February 14, 2024
Interferon-γ signaling in eosinophilic esophagitis has implications for epithelial barrier function and programmed cell death
Megha Lal, Caitlin M Burk, Ravi Gautam, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 30, 2025
Interferon-γ Signaling in Eosinophilic Esophagitis Affects Epithelial Barrier Function and Programmed Cell Death
Megha Lal, Caitlin M Burk, Ravi Gautam, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 15, 2019
Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantation
Caitlin M Burk, Kara E Coffey, Emily M Mace, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
GPR15 and CD38 define a subset of peripheral blood pathogenic effector Th2 cells associated with active eosinophilic esophagitis
Caitlin M Burk, Duncan M Morgan, Jonathan N Glickman, et al.
The Journal of Allergy and Clinical Immunology
|
August 15, 2016
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective
Brian P Vickery, Jelena P Berglund, Caitlin M Burk, et al.
Nature Immunology
|
April 8, 2024
TCF1-LEF1 co-expression identifies a multipotent progenitor cell (T<sub>H</sub>2-MPP) across human allergic diseases
Radomir Kratchmarov, Sarah Djeddi, Garrett Dunlap, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 6, 2026
Management of gastrointestinal symptoms during oral immunotherapy: Guidance from OUtMATCH Investigators
Sayantani B Sindher, Mirna Chehade, Evan S Dellon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Allergy and Clinical Immunology. in Practice
|
January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitization
J Andrew Bird, Matthew Feldman, Amy Arneson, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 12, 2026
Teff allergy in children with regular household exposure
Vivian Y Liu, Iris-Mae Morse, Aaron I Jaynes, et al.
Gastrointestinal Endoscopy
|
November 27, 2015
The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis
Swathi Eluri, Thomas M Runge, Cary C Cotton, et al.
Biorxiv : the Preprint Server for Biology
|
February 14, 2024
Interferon-γ signaling in eosinophilic esophagitis has implications for epithelial barrier function and programmed cell death
Megha Lal, Caitlin M Burk, Ravi Gautam, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
January 30, 2025
Interferon-γ Signaling in Eosinophilic Esophagitis Affects Epithelial Barrier Function and Programmed Cell Death
Megha Lal, Caitlin M Burk, Ravi Gautam, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 15, 2019
Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantation
Caitlin M Burk, Kara E Coffey, Emily M Mace, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
GPR15 and CD38 define a subset of peripheral blood pathogenic effector Th2 cells associated with active eosinophilic esophagitis
Caitlin M Burk, Duncan M Morgan, Jonathan N Glickman, et al.
The Journal of Allergy and Clinical Immunology
|
August 15, 2016
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective
Brian P Vickery, Jelena P Berglund, Caitlin M Burk, et al.
Nature Immunology
|
April 8, 2024
TCF1-LEF1 co-expression identifies a multipotent progenitor cell (T<sub>H</sub>2-MPP) across human allergic diseases
Radomir Kratchmarov, Sarah Djeddi, Garrett Dunlap, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 6, 2026
Management of gastrointestinal symptoms during oral immunotherapy: Guidance from OUtMATCH Investigators
Sayantani B Sindher, Mirna Chehade, Evan S Dellon, et al.
Page
of 3